+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Infectious Disease Diagnostic Market by Product (Instruments, Reagents, Software & Services), Technology (Biochemical Technology, Conventional Technology, Molecular Technology), Testing Type, Sample, Application, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829907
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Infectious Disease Diagnostic Market grew from USD 24.76 billion in 2023 to USD 26.44 billion in 2024. It is expected to continue growing at a CAGR of 7.29%, reaching USD 40.53 billion by 2030.

These diagnostics play a critical role in healthcare by facilitating the accurate and timely recognition of infectious agents, thus ensuring prompt and appropriate clinical management. The modalities for infectious disease diagnostics include culture techniques, molecular diagnostics, serology, antigen-based tests, and next-generation sequencing for guiding treatment decisions, monitoring disease outbreaks, and implementing infection control measures to prevent the spread of pathogens within communities and healthcare settings. In recent years, outbreaks of infectious diseases have resulted in an urgent need for reliable diagnostics. In addition, growth in healthcare spending and improvements in laboratory infrastructure globally contribute to the penetration of infectious disease diagnostic solutions. Moreover, government initiatives and regulatory approvals for innovative diagnostic solutions have expanded the availability of novel infectious disease diagnostic solutions. However, high costs associated with advanced diagnostic technologies could limit adoption in cost-sensitive regions. The lack of skilled professionals in emerging markets to operate sophisticated diagnostic equipment may restrict product penetration. Nevertheless, the integration of advanced technologies for enhanced data analysis and interpretation of complex diagnostic tests has enhanced the outputs of diagnostic tests. In addition, continuous development in diagnostic technologies, including rapid PCR systems and next-generation sequencing, drives the demand for infectious disease diagnostics products by offering quicker and more accurate results.

Regional Insights

The infectious disease diagnostic market in the Americas is observing rapid growth due to the increasing prevalence of infectious diseases, advanced diagnostic technologies, and growing awareness of early disease detection. The adoption of advanced technologies, well-established healthcare infrastructure, and the presence of the majority of vendors contribute to the infectious disease diagnostic market in the Americas. European Union's (EU) regulations and a sophisticated healthcare system largely influence Europe's market. EU countries invest heavily in research and innovation, exemplified by initiatives to foster the development of advanced diagnostics and resonate with proactive customer behavior toward disease prevention and management. The Middle East market is directed by significant healthcare spending and the adoption of high-tech diagnostic equipment, particularly in Gulf Cooperation Council (GCC) countries. The need for accessible and affordable diagnostics to combat prevalent infectious diseases such as HIV/AIDS, tuberculosis, and malaria has improved the need for infectious disease diagnosis products in Africa. The infectious disease diagnostic market in the Asia-Pacific is expanding rapidly due to its large population and increased healthcare expenditure. The government's focus on healthcare reform and the rise of domestic companies contribute to the growth of infectious disease diagnostics.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Infectious Disease Diagnostic Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing global prevalence and periodic outbreaks of infectious diseases
  • Shift in focus towards decentralized point-of-care testing from centralized laboratories
  • Supportive government initiatives and investments toward infectious disease control and prevention

Market Restraints

  • Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques

Market Opportunities

  • Advancements in infectious disease diagnostics kits and solutions
  • Emergence of infectious disease diagnostics kits for homecare settings

Market Challenges

  • Accuracy issues and limited availability of skilled professionals

Market Segmentation Analysis

  • Product: Advancing applications of analytical instruments for infectious disease diagnostics
  • Testing Type: Emerging adoption of Point-of-Care (PoC) testing for convenience and emergency applications
  • Application: Increasing use of disease diagnosis kits to diagnose viral infections
  • End-User: Penetration of infectious disease diagnosis products in hospitals

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infectious Disease Diagnostic Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infectious Disease Diagnostic Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica, headquartered in Espoo, Finland, strategically expanded its capabilities in the in vitro diagnostics (IVD) sector with the successful acquisition of ViroStat LLC, a Maine-based pioneer in developing viral antibodies and antigens. This move bolsters Medix Biochemica's product offerings with ViroStat's high-quality antibodies targeting respiratory and gastrointestinal infections, sexually transmitted diseases, and food-borne pathogens.

Oxford Nanopore and bioMérieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Oxford Nanopore Technologies partnered with bioMérieux SA, a provider of in vitro diagnostics, to enhance global health outcomes by introducing nanopore sequencing into infectious disease diagnostics. This alliance promises a leap forward in patient care, with Oxford Nanopore providing cutting-edge, cost-effective sequencing solutions that could significantly streamline and improve pathogen detection in clinical settings.

Thermo Fisher Scientific Launches PCR Kits for Infectious Disease Detection in India

Thermo Fisher Scientific unveiled its latest line of PCR kits tailored for infectious disease detection, marking a significant development for diagnostics in India. These PCR kits are designed to enhance the speed and accuracy of infectious disease diagnosis, enabling healthcare professionals to make more informed decisions and improve patient outcomes.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infectious Disease Diagnostic Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Infectious Disease Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, bioMérieux SA, Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Grifols, S.A., Hologic Inc., Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Labsystems Diagnostics Oy, Merck KGaA, Olympus Corporation, Perkin Elmer, Inc., Pfizer Inc., Qiagen N.V., Quest Diagnostics, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Infectious Disease Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Instruments
  • Reagents
  • Software & Services

Technology

  • Biochemical Technology
  • Conventional Technology
  • Molecular Technology

Testing Type

  • Laboratory Testing
  • PoC Testing

Sample

  • Blood, Plasma, & Serum
  • Urine

Application

  • Bacterial Infection
  • Cardiovascular Infection
  • CNS Infection
  • Fungal Infection
  • Sexually Transmitted Disease
  • Viral Infection

End User

  • Diagnostic Laboratories
  • Hospital
  • Research Institutes

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global prevalence and periodic outbreaks of infectious diseases
5.1.1.2. Shift in focus towards decentralized point-of-care testing from centralized laboratories
5.1.1.3. Supportive government initiatives and investments toward infectious disease control and prevention
5.1.2. Restraints
5.1.2.1. Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques
5.1.3. Opportunities
5.1.3.1. Advancements in infectious disease diagnostics kits and solutions
5.1.3.2. Emergence of infectious disease diagnostics kits for homecare settings
5.1.4. Challenges
5.1.4.1. Accuracy issues and limited availability of skilled professionals
5.2. Market Segmentation Analysis
5.2.1. Product: Advancing applications of analytical instruments for infectious disease diagnostics
5.2.2. Testing Type: Emerging adoption of Point-of-Care (PoC) testing for convenience and emergency applications
5.2.3. Application: Increasing use of disease diagnosis kits to diagnose viral infections
5.2.4. End-User: Penetration of infectious disease diagnosis products in hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Infectious Disease Diagnostic Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
6.4. Software & Services
7. Infectious Disease Diagnostic Market, by Technology
7.1. Introduction
7.2. Biochemical Technology
7.3. Conventional Technology
7.4. Molecular Technology
8. Infectious Disease Diagnostic Market, by Testing Type
8.1. Introduction
8.2. Laboratory Testing
8.3. PoC Testing
9. Infectious Disease Diagnostic Market, by Sample
9.1. Introduction
9.2. Blood, Plasma, & Serum
9.3. Urine
10. Infectious Disease Diagnostic Market, by Application
10.1. Introduction
10.2. Bacterial Infection
10.3. Cardiovascular Infection
10.4. CNS Infection
10.5. Fungal Infection
10.6. Sexually Transmitted Disease
10.7. Viral Infection
11. Infectious Disease Diagnostic Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospital
11.4. Research Institutes
12. Americas Infectious Disease Diagnostic Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Infectious Disease Diagnostic Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Infectious Disease Diagnostic Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering
15.3.2. Oxford Nanopore and bioMérieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
15.3.3. Thermo Fisher Scientific Launches PCR Kits for Infectious Disease Detection in India
15.4. Strategy Analysis & Recommendation
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio
List of Figures
FIGURE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS
FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, PLASMA, & SERUM, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, PLASMA, & SERUM, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 95. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 98. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 99. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 100. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 101. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 102. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 103. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 106. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 107. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 110. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 111. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 112. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 113. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 114. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 115. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 118. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 155. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 159. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 164. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 165. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 166. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 167. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 170. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 171. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 176. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 177. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 178. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 179. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 191. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 195. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 200. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 201. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 202. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 203. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 206. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 215. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 227. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 239. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 263. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 267. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 272. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 273. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 274. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 275. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 278. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 287. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 290. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 305. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 308. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 309. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 310. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 311. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
TABLE 312. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
TABLE 313. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 316. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 317. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 318. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 20

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • bioMérieux SA
  • Cardinal Health Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Grifols, S.A.
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Konica Minolta, Inc.
  • Labsystems Diagnostics Oy
  • Merck KGaA
  • Olympus Corporation
  • Perkin Elmer, Inc.
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 26.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 40.53 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal

Related Topics

Related Reports

Global Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Forecast to 2028 - Product Image

Global Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Forecast to 2028

  • Report
  • 303 Pages
  • Global
From
North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User - Product Image

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • Report
  • 115 Pages
  • North America
From
Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User - Product Image

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • Report
  • 136 Pages
  • Asia Pacific
From
Infectious Disease Diagnostics - Global Strategic Business Report - Product Image

Infectious Disease Diagnostics - Global Strategic Business Report

  • Report
  • 259 Pages
  • Global
From
Global Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Forecast 2024-2030 - Product Image

Global Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.